Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. 

Biotechnology

Education

Scorpion Therapeutics

Axel Hoos

Sadie Thompson

Andri Halim

Margaret Woo

Amanda Valentino

Brent Martin

Valerie Jaiswal

Michael Streit

Darrin Stuart

Angel Guzman-Perez

Adam Friedman

Brian Piper

Andrew Fedder

The board of directors at Scorpion Therapeutics is made up of individuals with a wide range of experience in the field of cancer research. These individuals have worked at some of the most prestigious institutions in the world, including the Massachusetts Institute of Technology (MIT) and the Massachusetts General Hospital (MGH). In addition to their extensive experience in cancer research, the members of the board also have a strong background in biology and biochemistry.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Scorpion Therapeutics

Leadership Team

CEO and Executive Team